CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis-Reference-Cited by-同舟云学术

CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis

Published:2022-09-22 Issue:18 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Zhang Lingjun,Borjini Nozha^ORCID,Lun Yu,Parab Sweta,Asonye Gospel,Singh Rupesh^ORCID,Bell Brent A.,Bonilha Vera L.^ORCID,Ivanov Andrei,Fox David A.^ORCID,Caspi Rachel,Lin Feng

Funder

NIH

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/157038/files/pdf

Reference37 articles.

1. Incidence and prevalence of uveitis in Northern California The Northern California Epidemiology of Uveitis Study

2. Regulation, Counter-Regulation, and Immunotherapy of Autoimmune Responses to Immunologically Privileged Retinal Antigens

3. Cytokines in Autoimmune Uveitis

4. Role of LFA‐1, ICAM‐1, VLA‐4 and VCAM‐1 in lymphocyte migration across retinal pigment epithelial monolayers in vitro

5. Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro;Liversidge;Immunology,1990

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CD318/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation;Journal of Autoimmunity;2024-06

2. CD6 triggers actomyosin cytoskeleton remodeling after binding to its receptor complex;Journal of Leukocyte Biology;2023-10-11

3. Identification of a novel inflammation-related gene signature for predicting inflammatory breast cancer survival;Genome Instability & Disease;2023-06-13

4. The dual role of CD6 as a therapeutic target in cancer and autoimmune disease;Frontiers in Medicine;2022-10-05